Sorry, you need to enable JavaScript to visit this website.

Study to Evaluate the Long‑Term Safety, Tolerability and Efficacy of Subcutaneous Marstacimab in Subjects With Severe Hemophilia

A Multicenter, Open‑Label Study to Evaluate the Long‑Term Safety, Tolerability and Efficacy of Subcutaneous PF‑06741086 in Subjects With Severe Hemophilia. A Multicenter, Open‑Label Study to Evaluate the
Long‑Term Safety, Tolerability and Efficacy of Subcutaneous PF‑06741086 in Subjects With Severe
Hemophilia

Category & Conditions: Rare Diseases
Medicine: marstacimab (PF-06741086)
ClinicalTrials.gov Identifier (NCT): NCT03363321
Protocol ID: B7841003
    Share
PrintDownload
Open Plain Language Summary Result: Click here